United States · FDA National Drug Code directory
VITRAKVI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71777-391_5b9e7961-f843-49d8-94b5-a2ce2c9efa46
- Product NDC
- 71777-391
- Form
- CAPSULE
- Composition / generic term
- LAROTRECTINIB
- Labeler
- Loxo Oncology, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181126
- Source listing expiry
- 20261231
Source-listed ingredients
- LAROTRECTINIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (71777-391-01) · 71777-391-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →